The poisonous one of influenza shares the agreement and has not reached yet

The poisonous one of influenza shares the agreement and has not reached yet
The poisonous one of influenza shares the agreement and has not reached yet
Every member representative of World Health Organization concludes on the 16th about sharing the poisonous negotiation of one of first type H1N1 influenza virus, two major camps composed of members and the regional members in the development in the developed area have not reached an agreement. The focuses of the disputes of both sides concentrate on utilizing and sharing the virus sample vaccine developed and is offered to every member by the par, patent according to the ordinary medicines mode. Not publishing the agreement, negotiation of this is launched in the general headquarters of World Health Organization Geneva, have discussed for two days altogether. After the negotiation, organize and then issue a statement, declare the negotiation makes some progress, but not reached an agreement. The declaration says: "This negotiation is sharing influenza virus sample and obtaining vaccine,etc. the main respect of the achievement is making the achievement, but some key parts still need to continue consulting. " What is called key part, mean every member shares the virus virus sample, obtain vaccine in regional member's par when could guarantee to develop. Every member representative agrees, the achievement that will be already made and main obstacle of reaching an agreement are referred to World Health Assembly held and discussed. Very fast because of the speed of mutation of influenza, it is extremely important to share the poisonous one of virus to researching and developing vaccine. Margaret Chan, Secretary General of WHO, says while opening at the meeting on the 15th: "Our crisis for the moment may influence the whole world. What the world needs most promptly now is the information as overall as possible. " Where is the obstacle main obstacle preventing two major camps from reaching an agreement is how every member obtain vaccine. WHO hopes, can obtain the virus sample in laboratory and every drugmaker all around the world, in order to help them develop vaccine. Regional members hope to obtain vaccine at the nominal price while developing, especially when developing countries or areas offers the virus sample. The developed area members headed by U.S.A. think, should operate this according to the commercial operation procedure of medicines, patent for vaccine, guarantee the drugmaker is lucrative. The similar dispute has it long ago. In 2006, U.S.A.'s disease controlled and prevented the centre and patented for a new kind of influenza vaccine, register it in World Intellectual Property Organization next year. This kind of vaccine uses the virus gene obtained in 2005 while developing, come from a high pathogenic bird flu died person of H5N1 type in Indonesia. Indonesia refuses to continue sharing bird flu virus sample in 2007, unless developing countries can get the assurance of obtaining vaccine at a low price. How influenza virus sample originally has dispute to shift too, regional members hope to reach the agreement on the overall sample shifts in development, receive developed area members to object to. Developed area members basically agree finally, the biomaterial related to this influenza is shifted through WHO's channel, the intellectual property right principle is no longer applicable. Vaccine produce overall malicious share, reach an agreement, represent vaccine produce stagnation this right away yet. For the moment, some appear first type the intersection of H1N1 and the intersection of influenza and country to make a definite diagnosis of case already begin for risk assessment and produce " a kind of vaccine " Share the virus sample, is ready for producing vaccine on a large scale. First type H1N1 influenza " Plant vaccine " Controlled and prevented from centre's developing from U.S.A.'s disease, it is expected to make within several weeks. In addition, WHO takes some measures on this too. Simple Halton of officer of hygiene of Australia who is in charge of sharing the poison one and consulting says: " the reality is, this (poisonous one shares) The system was always built up, some work of the relevant field has already begun. " If produce first type H1N1 influenza vaccine on a large scale, every large drugmaker may cut down the vaccine production of seasonal influenza, in order to raise the vaccine output of first type H1N1 influenza. (Wang FengFeng)


|